Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of prescribing oral anticoagulation
therapy by pharmacist intervention compared to enhanced usual care in participants with
unrecognized AF and/or known AF but not taking blood thinners.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alberta
Collaborators:
Canadian Stroke Prevention Intervention Network Heart and Stroke Foundation of Canada